- £87.75m
- £83.59m
- $43.92m
- 51
- 11
- 26
- 16
RCS - AOTI, Inc. - Investor Presentation via Investor Meet Company
AnnouncementREG - AOTI, Inc. - TWO2® in NHS supply chain framework agreement
AnnouncementREG - AOTI, Inc. - Notification of Major Holdings
AnnouncementREG - AOTI, Inc. - Director/PDMR Shareholding
AnnouncementREG - AOTI, Inc. - Trading Update for the year ended 31 December 2024
AnnouncementREG - AOTI, Inc. - New Medicaid states, payer coverage expansion
AnnouncementREG - AOTI, Inc. - Grant of performance share awards under LTIP
AnnouncementREG - AOTI, Inc. - Enrolment Commences for VLU Clinical Trial
AnnouncementREG - AOTI, Inc. - 5 Year Veterans Administration Contract Extension
AnnouncementREG - AOTI, Inc. - Holding(s) in Company
AnnouncementREG - AOTI, Inc. - CMS Topical Oxygen Therapy coverage review
AnnouncementREG - AOTI, Inc. - 2024 Interim Results
AnnouncementREG - AOTI, Inc. - Pre-close Trading Update
AnnouncementREG - AOTI, Inc. - US FDA 510(k) Clearance of NEXATM NPWT System
AnnouncementREG - AOTI, Inc. - Holding(s) in Company
AnnouncementREG - AOTI, Inc. - Holding(s) in Company
AnnouncementREG - AOTI, Inc. - Admission to AIM and First Day of Dealings
Announcement